Search
Galactose-uridine-5'-diphosphate
go.drugbank.com/drugs/DB03501ExperimentalServes as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose.
SYNB1020
go.drugbank.com/drugs/DB17667InvestigationalIt was initially designed to convert ammonia to L-arginine [A258838] and granted orphan designation by the FDA for the treatment of urea cycle disorders in August 2016;[L45988] however, the manufacturer
Mivebresib
go.drugbank.com/drugs/DB21300InvestigationalMivebresib has a monoisotopic molecular weight of 459.11 Da.
Brecanavir
go.drugbank.com/drugs/DB04887InvestigationalThe decision was based on issues regarding the formulation of the drug.
Nelotanserin
go.drugbank.com/drugs/DB12555InvestigationalNelotanserin has been used in trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and REM Sleep Behavior Disorder.
SAR445136
go.drugbank.com/drugs/DB17708Investigational[A259063] It was formerly investigated for the treatment of beta-thalassemia, and it is currently being investigated for the treatment of sickle cell disease.[L46148]
Faxeladol
go.drugbank.com/drugs/DB20529InvestigationalFaxeladol has a monoisotopic molecular weight of 233.18 Da.
Flizasertib
go.drugbank.com/drugs/DB21613InvestigationalFlizasertib has a monoisotopic molecular weight of 271.11 Da.
Razuprotafib
go.drugbank.com/drugs/DB16353InvestigationalRazuprotafib, also known as AKB-9778, is a small-molecule inhibitor restoring Tie2 activation by inhibiting VE-PTP.
Dialyzable leukocyte extract
go.drugbank.com/drugs/DB16530InvestigationalTransferon is comprised of several peptides mixed from human dialyzable leucocyte extracts and acts as an immunomodulator.